Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Chang TKH, Weber GF, Crespi CL and Waxman DJ (1993) Differential activation of cyclophosphamide and ifosfamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res 53: 5629–5637
Marre F, Sanderink GJ, de Sousa G, Gaillard C, Martinet M and Rahmani R (1996) Hepatic biotransformation of docetaxel (taxotere) in vitro: involvement of the CYP3A subfamily in humans. Cancer Res 56: 1296–1302
Pronk LC, Schrijvers D, Schellens JHM, de Bruijn EA, Planting ASTh, Locci-Tonelli D, Groult V, Verweij J and van Oosterom AT (1998) Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours. Br J Cancer 77: 153–158
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Possible metabolic interaction between docetaxel and ifosfamide. Br J Cancer 82, 497 (2000). https://doi.org/10.1054/bjoc.1999.0949
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.0949
This article is cited by
-
Reconsidering the duty to warn genetically at-risk relatives
Genetics in Medicine (2018)